Home2575 • HKG
add
Xuanzhu Biopharmaceutical Co Ltd
Previous close
$26.30
Day range
$23.82 - $29.00
Year range
$23.82 - $31.00
Avg Volume
491.48K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 8.95M | 11.62% |
Operating expense | 60.01M | 2.52% |
Net income | -55.45M | 0.06% |
Net profit margin | -619.85 | 10.47% |
Earnings per share | — | — |
EBITDA | -48.48M | -4.66% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 109.75M | — |
Total assets | 1.07B | — |
Total liabilities | 220.50M | — |
Total equity | 845.80M | — |
Shares outstanding | 443.64M | — |
Price to book | 13.77 | — |
Return on assets | -12.87% | — |
Return on capital | -16.21% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -55.45M | 0.06% |
Cash from operations | -61.38M | -132.08% |
Cash from investing | -909.00K | 97.05% |
Cash from financing | -1.04M | 27.80% |
Net change in cash | -63.35M | -7.77% |
Free cash flow | -34.30M | — |
About
Founded
2008
Website
Employees
197